Patent_application_number,Applicant_name,Year_of_application,Patent_system
KR20210006966A,"CARIBOU BIOSCIENCES, INC",2021,KIPO
KR20210013304A,HARVARD MEDICAL SCHOOL,2021,KIPO
KR20210023842A,CHR HANSEN,2021,KIPO
KR20210027606A,"INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY",2021,KIPO
KR20210031678A,"TIANJIN INSTITUTE OF INDUSTRIAL BIOTECHNOLOGY, CHINESE ACADEMY OF SCIENCES",2021,KIPO
KR20210037983A,KIST,2021,KIPO
KR20210039115A,DONG-EUI UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION|MYONGJI UNIVERSITY INDUSTRY AND ACADEMIA COOPERATION FOUNDATION,2021,KIPO
KR20210039290A,KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION,2021,KIPO
KR20210043562A,PRECIGEN,2021,KIPO
KR20210046725A,"1GLOBE BIOMEDICAL CO., LTD.|1GLOBE HEALTH INSTITUTE LLC",2021,KIPO
KR20210047196A,DONGGUK UNIVERSITY GYEONGJU CAMPUS INDUSTRY-ACADEMY COOPERATION FOUNDATION,2021,KIPO
KR20210047690A,"JINIS CO.,LTD",2021,KIPO
KR20210047891A,UNIVERSITY OF PENNSYLVANIA,2021,KIPO
KR20210049023A,CONTRAFECT CORPORATION,2021,KIPO
KR20210049805A,UNIVERSITY OF CALIFORNIA,2021,KIPO
KR20210049859A,"FLAGSHIP PIONEERING INNOVATIONS VI, LLC",2021,KIPO
KR20210050324A,CJ CHEILJEDANG CORP,2021,KIPO
KR20210052110A,DAESANG CORPORATION,2021,KIPO
KR20210053912A,"AKESO BIOPHARMA, INC",2021,KIPO
KR20210060521A,ETH ZURICH,2021,KIPO
KR20210062959A,KNU-INDUSTRY COOPERATION FOUNDATION,2021,KIPO
KR20210068487A,PIERRE FABRE MEDICAMENT,2021,KIPO
KR20210070305A,AERA HERPEUTICS INC,2021,KIPO
KR20210072147A,"GENOMATICA, INC",2021,KIPO
KR20210074722A,CHONNAM NATIONAL UNIVERSITY,2021,KIPO
KR20210077585A,UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY,2021,KIPO
KR20210079404A,BAYER,2021,KIPO
KR20210079405A,BAYER,2021,KIPO